Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Callaghan

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Irish Journal of Medical Science|August 13, 2016
The therapeutic range for phenytoin - A reappraisalM Feeley, B Duggan, M O'Callagan, et al.
Acta Neurologica Scandinavica|July 1, 1977
The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levelsN Callaghan, M Feely, F Duggan, et al.
The Journal of Pediatrics|February 1, 1984
Sodium valproate re epilepsyM J Conran, P J Kearney, N Callaghan, et al.
The Quarterly Journal of Medicine|February 1, 1991
A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalaciaN Collins, J Maher, M Cole, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1982
Brain transmitter precursors and metabolites in diabetic ketoacidosisG Curzon, B D Kantamaneni, N Callaghan, et al.
Irish Journal of Medical Science|February 1, 1979
The therapeutic range for phenytoin--a reappraisalM Feeley, B Duggan, M O'Callagan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 24, 2001
Accuracy and limitations of transabdominal fetal echocardiography at 12-15 weeks of gestation in a population at high risk for congenital heart diseaseJ M Simpsom, A Jones, N Callaghan, et al.
Developmental Medicine and Child Neurology|December 1, 1982
Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)N Callaghan, J O'Hare, D O'Driscoll, et al.
ANZ Journal of Surgery|September 18, 2008
Who's on first?Kathleen S N Callaghan, Rachel P Roskvist, Graham J F Hunt
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1985
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsyN Callaghan, R A Kenny, B O'Neill, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Irish Journal of Medical Science|August 13, 2016
The therapeutic range for phenytoin - A reappraisalM Feeley, B Duggan, M O'Callagan, et al.
Acta Neurologica Scandinavica|July 1, 1977
The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levelsN Callaghan, M Feely, F Duggan, et al.
The Journal of Pediatrics|February 1, 1984
Sodium valproate re epilepsyM J Conran, P J Kearney, N Callaghan, et al.
The Quarterly Journal of Medicine|February 1, 1991
A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalaciaN Collins, J Maher, M Cole, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1982
Brain transmitter precursors and metabolites in diabetic ketoacidosisG Curzon, B D Kantamaneni, N Callaghan, et al.
Irish Journal of Medical Science|February 1, 1979
The therapeutic range for phenytoin--a reappraisalM Feeley, B Duggan, M O'Callagan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 24, 2001
Accuracy and limitations of transabdominal fetal echocardiography at 12-15 weeks of gestation in a population at high risk for congenital heart diseaseJ M Simpsom, A Jones, N Callaghan, et al.
Developmental Medicine and Child Neurology|December 1, 1982
Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)N Callaghan, J O'Hare, D O'Driscoll, et al.
ANZ Journal of Surgery|September 18, 2008
Who's on first?Kathleen S N Callaghan, Rachel P Roskvist, Graham J F Hunt
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1985
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsyN Callaghan, R A Kenny, B O'Neill, et al.
Pageof 8